33 related articles for article (PubMed ID: 27744027)
1. Management of COVID-19 pneumonia in a child with NEMO deficiency.
Alkan G; Artac H; Oz SKT; Emiroglu M
Immunol Res; 2021 Aug; 69(4):391-393. PubMed ID: 34061330
[No Abstract] [Full Text] [Related]
2. Successful Allogeneic Stem Cell Transplantation in Nuclear Factor-Kappa B Essential Modulator Deficiency Syndrome After Treosulfan-Based Conditioning: A Case Report.
Martuszewski A; Paluszkiewicz P; Sierżęga-Staykov K; Wawrzyniak-Dzierżek E; Salamonowicz-Bodzioch M; Frączkiewicz J; Janeczko-Czarnecka M; Mielcarek-Siedziuk M; Nowak M; Dąbrowska-Leonik N; Wolska-Kuśnierz B; Gul K; Bąbol-Pokora K; Młynarski W; Kałwak K; Ussowicz M
Transplant Proc; 2020 Mar; 52(2):647-652. PubMed ID: 32035679
[TBL] [Abstract][Full Text] [Related]
3. Challenges in the use of allogeneic hematopoietic SCT for ectodermal dysplasia with immune deficiency.
Fish JD; Duerst RE; Gelfand EW; Orange JS; Bunin N
Bone Marrow Transplant; 2009 Feb; 43(3):217-21. PubMed ID: 18794870
[TBL] [Abstract][Full Text] [Related]
4. Correction of immunodeficiency associated with NEMO mutation by umbilical cord blood transplantation using a reduced-intensity conditioning regimen.
Tono C; Takahashi Y; Terui K; Sasaki S; Kamio T; Tandai S; Sato T; Kudo K; Toki T; Tachibana N; Yoshioka T; Nakahata T; Morio T; Nishikomori R; Ito E
Bone Marrow Transplant; 2007 Jun; 39(12):801-4. PubMed ID: 17417663
[No Abstract] [Full Text] [Related]
5. Infliximab therapy for inflammatory colitis in an infant with NEMO deficiency.
Artac H; Emsen A; Ucaryilmaz H; Emiroglu HH; Uygun V; Stray-Pedersen A
Immunol Res; 2019 Oct; 67(4-5):450-453. PubMed ID: 31713830
[No Abstract] [Full Text] [Related]
6. Allogeneic transplantation successfully corrects immune defects, but not susceptibility to colitis, in a patient with nuclear factor-kappaB essential modulator deficiency.
Pai SY; Levy O; Jabara HH; Glickman JN; Stoler-Barak L; Sachs J; Nurko S; Orange JS; Geha RS
J Allergy Clin Immunol; 2008 Dec; 122(6):1113-1118.e1. PubMed ID: 18851875
[TBL] [Abstract][Full Text] [Related]
7. Outcome of patients with NEMO deficiency following allogeneic hematopoietic cell transplant.
Chandrakasan S; Marsh RA; Uzel G; Holland SM; Shah KN; Bleesing J
J Allergy Clin Immunol; 2017 Mar; 139(3):1040-1043.e2. PubMed ID: 27744027
[No Abstract] [Full Text] [Related]
8. Allogeneic hematopoietic stem cell transplantation for X-linked ectodermal dysplasia and immunodeficiency: case report and review of outcomes.
Permaul P; Narla A; Hornick JL; Pai SY
Immunol Res; 2009; 44(1-3):89-98. PubMed ID: 19225723
[TBL] [Abstract][Full Text] [Related]
9. EDA-ID and IP, two faces of the same coin: how the same IKBKG/NEMO mutation affecting the NF-κB pathway can cause immunodeficiency and/or inflammation.
Fusco F; Pescatore A; Conte MI; Mirabelli P; Paciolla M; Esposito E; Lioi MB; Ursini MV
Int Rev Immunol; 2015; 34(6):445-59. PubMed ID: 26269396
[TBL] [Abstract][Full Text] [Related]
10. Hematopoietic stem cell transplantation for primary immunodeficiencies.
Kang E; Gennery A
Hematol Oncol Clin North Am; 2014 Dec; 28(6):1157-70. PubMed ID: 25459185
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and treatment in anhidrotic ectodermal dysplasia with immunodeficiency.
Kawai T; Nishikomori R; Heike T
Allergol Int; 2012 Jun; 61(2):207-17. PubMed ID: 22635013
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
